SIETES :: 93213 citas

Resultados de la búsqueda por Montastruc,J-L REFINAR BÚSQUEDA

21.

Olivier P, Montastruc J-L. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Pharmacoepidemiol Drug Saf 2006;15:808-12. [Ref.ID 88737]

22.

Gony M, Badie K, Sommet A, Jacquot J, Baudrin D, Gauthier P, Montastruc J-L, Bagheri H. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées Region (PharmacoMIP) Network 2-year pilot study. Drug Saf 2010;33:409-16. [Ref.ID 88434]

23.

Montastruc G, Favreliere S, Sommet A, Pathak A, Lapeyre-Mestre M, Perault-Pochat M-C, Montastruc J-L, The French Association of Regional PharmacoVigilance Centres. Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance Database. Br J Clin Pharmacol 2010;69:marzo. [Ref.ID 87941]

24.

Lacroix I, Hurault C, Sarramon MF, Guitard C, Berrebi A, Grau M, Albouy-Cossard C, Bourrel R, Elefant E, Montastruc J-L, Damase-Michel C. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol 2009;65:839-46. [Ref.ID 86606]

25.

Fuzier R, Lapeyre-Mestre M, Mertes P-M, Nicolas J-F, Benoit Y, Didier A, Albert N, Montastruc J-L, and the French Association of Regional Pharmacovigilance Centers. Immediate- and delayed-type allergic reactions to amide local anesthetics: clinical features and skin testing. Pharmacoepidemiol Drug Saf 2009;18:595-601. [Ref.ID 86272]

26.

Montastruc G, Degand B, Montastruc J-L, Perault-Pochat M-C. Arrêt cardiaque récupéré sous varénicline: à propos d'un cas. Therapie 2009;64:65-6. [Ref.ID 86032]

27.

Fuzier R, Lapeyre-Mestre M, Samii K, Montastruc J-L, and the French Association of Regional Pharmacovigilance Centres. Adverse drug reactions to local anaesthetics: a review of the French Pharmacovigilance Database. Drug Saf 2009;32:345-56. [Ref.ID 85766]

28.

Sommet A, Pathak A, Montastruc J-L. Tesofensine and weight loss. Lancet 2009;373:719. [Ref.ID 85373]

29.

Tavassoli N, Montastruc-Fournier J, Montastruc J-L, & The French Association of Regional Pharmacovigilance Centres. Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses. Br J Clin Pharmacol 2008;66:566-7. [Ref.ID 84100]

30.

Gallini A, Sommet A, Montastruc J-L, and the French PharmacoVigilance Network. Does memantine induce bradycardia? A study in the French FarmacoVigilance Database. Pharmacoepidemiol Drug Saf 2008;17:877-81. [Ref.ID 83994]

31.

Molokhia M, Pathak A, Lapeyre-Mestre M, Caturla L, Montastruc J-L, L'Association Française des Centres Régionaux de Pharmacovigilance (CRPV), McKeigue P. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. Br J Clin Pharmacol 2008;66:386-95. [Ref.ID 83923]

32.

Lugardon S, Roussel H, Sciortino V, Montastruc J-L, Laeypre-Mestre M. Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database. Eur J Clin Pharmacol 2007;63:801-7. [Ref.ID 80786]

33.

Leclerc-Foucras S, Bagheri H, Samii K, Montastruc J-L, Lapeyre-Mestre M. Modifications of low-molecular weight heparin use in a French University Hospital after implementation of new guidelines. Drug Saf 2007;30:409-17. [Ref.ID 80154]

34.

Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc J-L, Bagheri H. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 2007;63:221-8. [Ref.ID 79523]

35.

Michenot F, Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc J-L, and the French Network of PharmacoVigilance centres. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: a study from the French PharmacoVigilance Database. Pharmacoepidemiol Drug Saf 2006;15:735-40. [Ref.ID 78584]

36.

Sommet A, Juillard-Condat B, Cestac P, Lapeyre-Mestre M, Montastruc J-L. Méthodes de mesure de la consommation médicamenteuse: application aux antibiotiques. Therapie 2005;60:553-9. [Ref.ID 76311]

37.

Durrieu G, Olivier P, Montastruc J-L, The French networks of Pharmacovigilance centers. COX-2 inhibitors and arterial hypertension: an analysis of spontaneous case reports in the Pharmacovigilance database. Eur J Clin Pharmacol 2005;61:611-4. [Ref.ID 75027]

38.

Bagheri H, Simiand E, Montastruc J-L, Magnaval J-F. Adverse drug reactions to anthelmintics. Ann Pharmacother 2004;38:383-8. [Ref.ID 74525]

39.

Olivier P, Caron J, Haramburu F, Imbs JL, Jonville-Bera AP, Lagier G, Sgro C, Vial T, Montastruc J-L, Lapeyre-Mestre M. Validation of a measurement scale: example of a French adverse drug reactions preventability scale. Therapie 2005;60:39-45. [Ref.ID 73887]

40.

Souchet E, Lapeyre-Mestre M, Montastruc J-L. Drug related falls: a study in the French Pharmacovigilance database. Pharmacoepidemiol Drug Saf 2005;14:11-6. [Ref.ID 72635]